London - Elderly women with breast cancer are not being offered life-prolonging surgery because of discrimination and ageism in healthcare services, British researchers said yesterday.
Women in their 70s in Britain and elsewhere are often only given the drug Tamox ifen for breast cancer, while their younger counterparts have surgery as well as the hormone therapy. But a new study shows that surgery and Tamoxifen would also benefit elderly women.